nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—ABCC3—Fluorouracil—skin cancer	0.272	0.359	CbGbCtD
Gadoxetate—ABCC4—Fluorouracil—skin cancer	0.208	0.274	CbGbCtD
Gadoxetate—SLCO1B3—Docetaxel—skin cancer	0.184	0.243	CbGbCtD
Gadoxetate—ABCC2—Docetaxel—skin cancer	0.0943	0.124	CbGbCtD
Gadoxetate—Loss of consciousness—Imiquimod—skin cancer	0.000743	0.00307	CcSEcCtD
Gadoxetate—Irritability—Fluorouracil—skin cancer	0.00074	0.00306	CcSEcCtD
Gadoxetate—Cough—Imiquimod—skin cancer	0.000738	0.00305	CcSEcCtD
Gadoxetate—Convulsion—Imiquimod—skin cancer	0.000733	0.00303	CcSEcCtD
Gadoxetate—Abdominal distension—Temozolomide—skin cancer	0.000732	0.00303	CcSEcCtD
Gadoxetate—Fluid retention—Docetaxel—skin cancer	0.000732	0.00303	CcSEcCtD
Gadoxetate—Dysphagia—Temozolomide—skin cancer	0.000727	0.00301	CcSEcCtD
Gadoxetate—Chest pain—Imiquimod—skin cancer	0.00072	0.00298	CcSEcCtD
Gadoxetate—Anxiety—Imiquimod—skin cancer	0.000717	0.00297	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000715	0.00296	CcSEcCtD
Gadoxetate—Discomfort—Imiquimod—skin cancer	0.000711	0.00294	CcSEcCtD
Gadoxetate—Sweating increased—Temozolomide—skin cancer	0.000708	0.00293	CcSEcCtD
Gadoxetate—Dry mouth—Imiquimod—skin cancer	0.000704	0.00291	CcSEcCtD
Gadoxetate—Decreased appetite—Vemurafenib—skin cancer	0.000703	0.00291	CcSEcCtD
Gadoxetate—Bronchitis—Temozolomide—skin cancer	0.000699	0.00289	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000699	0.00289	CcSEcCtD
Gadoxetate—Fatigue—Vemurafenib—skin cancer	0.000698	0.00288	CcSEcCtD
Gadoxetate—Constipation—Vemurafenib—skin cancer	0.000692	0.00286	CcSEcCtD
Gadoxetate—Oedema—Imiquimod—skin cancer	0.00069	0.00285	CcSEcCtD
Gadoxetate—Lightheadedness—Docetaxel—skin cancer	0.00069	0.00285	CcSEcCtD
Gadoxetate—Hypoaesthesia—Bleomycin—skin cancer	0.000687	0.00284	CcSEcCtD
Gadoxetate—Infection—Imiquimod—skin cancer	0.000686	0.00283	CcSEcCtD
Gadoxetate—Shock—Imiquimod—skin cancer	0.000679	0.00281	CcSEcCtD
Gadoxetate—Nervous system disorder—Imiquimod—skin cancer	0.000677	0.0028	CcSEcCtD
Gadoxetate—Tachycardia—Imiquimod—skin cancer	0.000673	0.00278	CcSEcCtD
Gadoxetate—Skin disorder—Imiquimod—skin cancer	0.00067	0.00277	CcSEcCtD
Gadoxetate—Dysphagia—Fluorouracil—skin cancer	0.00067	0.00277	CcSEcCtD
Gadoxetate—Sepsis—Docetaxel—skin cancer	0.000669	0.00277	CcSEcCtD
Gadoxetate—Hyperhidrosis—Imiquimod—skin cancer	0.000667	0.00276	CcSEcCtD
Gadoxetate—Anorexia—Imiquimod—skin cancer	0.000658	0.00272	CcSEcCtD
Gadoxetate—Phlebitis—Docetaxel—skin cancer	0.000649	0.00269	CcSEcCtD
Gadoxetate—Flushing—Bleomycin—skin cancer	0.00064	0.00265	CcSEcCtD
Gadoxetate—Body temperature increased—Vemurafenib—skin cancer	0.00064	0.00264	CcSEcCtD
Gadoxetate—Swelling—Docetaxel—skin cancer	0.000634	0.00262	CcSEcCtD
Gadoxetate—Paraesthesia—Imiquimod—skin cancer	0.00062	0.00256	CcSEcCtD
Gadoxetate—Chills—Bleomycin—skin cancer	0.000619	0.00256	CcSEcCtD
Gadoxetate—Cardiac failure congestive—Docetaxel—skin cancer	0.000617	0.00255	CcSEcCtD
Gadoxetate—Dyspnoea—Imiquimod—skin cancer	0.000615	0.00254	CcSEcCtD
Gadoxetate—Decreased appetite—Imiquimod—skin cancer	0.0006	0.00248	CcSEcCtD
Gadoxetate—Flushing—Dactinomycin—skin cancer	0.000597	0.00247	CcSEcCtD
Gadoxetate—Hypersensitivity—Vemurafenib—skin cancer	0.000596	0.00246	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Imiquimod—skin cancer	0.000596	0.00246	CcSEcCtD
Gadoxetate—Fatigue—Imiquimod—skin cancer	0.000595	0.00246	CcSEcCtD
Gadoxetate—Acute coronary syndrome—Fluorouracil—skin cancer	0.000589	0.00243	CcSEcCtD
Gadoxetate—Renal impairment—Docetaxel—skin cancer	0.000588	0.00243	CcSEcCtD
Gadoxetate—Myocardial infarction—Fluorouracil—skin cancer	0.000586	0.00242	CcSEcCtD
Gadoxetate—Conjunctivitis—Fluorouracil—skin cancer	0.000581	0.0024	CcSEcCtD
Gadoxetate—Asthenia—Vemurafenib—skin cancer	0.000581	0.0024	CcSEcCtD
Gadoxetate—Hypoaesthesia—Temozolomide—skin cancer	0.000579	0.00239	CcSEcCtD
Gadoxetate—Chills—Dactinomycin—skin cancer	0.000577	0.00239	CcSEcCtD
Gadoxetate—Pruritus—Vemurafenib—skin cancer	0.000572	0.00237	CcSEcCtD
Gadoxetate—Connective tissue disorder—Temozolomide—skin cancer	0.000572	0.00236	CcSEcCtD
Gadoxetate—Feeling abnormal—Imiquimod—skin cancer	0.000569	0.00235	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Imiquimod—skin cancer	0.000564	0.00233	CcSEcCtD
Gadoxetate—Ill-defined disorder—Bleomycin—skin cancer	0.000557	0.0023	CcSEcCtD
Gadoxetate—Diarrhoea—Vemurafenib—skin cancer	0.000554	0.00229	CcSEcCtD
Gadoxetate—Urticaria—Imiquimod—skin cancer	0.000548	0.00227	CcSEcCtD
Gadoxetate—Abdominal pain—Imiquimod—skin cancer	0.000546	0.00226	CcSEcCtD
Gadoxetate—Body temperature increased—Imiquimod—skin cancer	0.000546	0.00226	CcSEcCtD
Gadoxetate—Malaise—Bleomycin—skin cancer	0.000542	0.00224	CcSEcCtD
Gadoxetate—Flushing—Temozolomide—skin cancer	0.00054	0.00223	CcSEcCtD
Gadoxetate—Cardiac disorder—Temozolomide—skin cancer	0.00054	0.00223	CcSEcCtD
Gadoxetate—Rhinitis—Fluorouracil—skin cancer	0.000538	0.00222	CcSEcCtD
Gadoxetate—Dizziness—Vemurafenib—skin cancer	0.000535	0.00221	CcSEcCtD
Gadoxetate—Hypoaesthesia—Fluorouracil—skin cancer	0.000534	0.00221	CcSEcCtD
Gadoxetate—Angiopathy—Temozolomide—skin cancer	0.000528	0.00218	CcSEcCtD
Gadoxetate—Immune system disorder—Temozolomide—skin cancer	0.000526	0.00217	CcSEcCtD
Gadoxetate—Mediastinal disorder—Temozolomide—skin cancer	0.000525	0.00217	CcSEcCtD
Gadoxetate—Cough—Bleomycin—skin cancer	0.000524	0.00217	CcSEcCtD
Gadoxetate—Chills—Temozolomide—skin cancer	0.000522	0.00216	CcSEcCtD
Gadoxetate—Dehydration—Docetaxel—skin cancer	0.00052	0.00215	CcSEcCtD
Gadoxetate—Ill-defined disorder—Dactinomycin—skin cancer	0.00052	0.00215	CcSEcCtD
Gadoxetate—Vomiting—Vemurafenib—skin cancer	0.000514	0.00213	CcSEcCtD
Gadoxetate—Chest pain—Bleomycin—skin cancer	0.000511	0.00211	CcSEcCtD
Gadoxetate—Rash—Vemurafenib—skin cancer	0.00051	0.00211	CcSEcCtD
Gadoxetate—Dermatitis—Vemurafenib—skin cancer	0.00051	0.00211	CcSEcCtD
Gadoxetate—Hypersensitivity—Imiquimod—skin cancer	0.000508	0.0021	CcSEcCtD
Gadoxetate—Headache—Vemurafenib—skin cancer	0.000507	0.0021	CcSEcCtD
Gadoxetate—Discomfort—Bleomycin—skin cancer	0.000505	0.00209	CcSEcCtD
Gadoxetate—Malaise—Dactinomycin—skin cancer	0.000505	0.00209	CcSEcCtD
Gadoxetate—Dysgeusia—Temozolomide—skin cancer	0.000496	0.00205	CcSEcCtD
Gadoxetate—Asthenia—Imiquimod—skin cancer	0.000495	0.00205	CcSEcCtD
Gadoxetate—Anaphylactic shock—Bleomycin—skin cancer	0.00049	0.00203	CcSEcCtD
Gadoxetate—Oedema—Bleomycin—skin cancer	0.00049	0.00203	CcSEcCtD
Gadoxetate—Back pain—Temozolomide—skin cancer	0.00049	0.00203	CcSEcCtD
Gadoxetate—Pruritus—Imiquimod—skin cancer	0.000488	0.00202	CcSEcCtD
Gadoxetate—Infection—Bleomycin—skin cancer	0.000487	0.00201	CcSEcCtD
Gadoxetate—Dysphagia—Docetaxel—skin cancer	0.000484	0.002	CcSEcCtD
Gadoxetate—Nausea—Vemurafenib—skin cancer	0.000481	0.00199	CcSEcCtD
Gadoxetate—Arrhythmia—Fluorouracil—skin cancer	0.000479	0.00198	CcSEcCtD
Gadoxetate—Vision blurred—Temozolomide—skin cancer	0.000478	0.00197	CcSEcCtD
Gadoxetate—Bronchospasm—Docetaxel—skin cancer	0.000476	0.00197	CcSEcCtD
Gadoxetate—Tremor—Temozolomide—skin cancer	0.000475	0.00196	CcSEcCtD
Gadoxetate—Diarrhoea—Imiquimod—skin cancer	0.000472	0.00195	CcSEcCtD
Gadoxetate—Discomfort—Dactinomycin—skin cancer	0.000471	0.00195	CcSEcCtD
Gadoxetate—Ill-defined disorder—Temozolomide—skin cancer	0.00047	0.00194	CcSEcCtD
Gadoxetate—Anorexia—Bleomycin—skin cancer	0.000467	0.00193	CcSEcCtD
Gadoxetate—Agitation—Temozolomide—skin cancer	0.000466	0.00193	CcSEcCtD
Gadoxetate—Hypotension—Bleomycin—skin cancer	0.000458	0.00189	CcSEcCtD
Gadoxetate—Oedema—Dactinomycin—skin cancer	0.000457	0.00189	CcSEcCtD
Gadoxetate—Malaise—Temozolomide—skin cancer	0.000457	0.00189	CcSEcCtD
Gadoxetate—Dizziness—Imiquimod—skin cancer	0.000456	0.00189	CcSEcCtD
Gadoxetate—Vertigo—Temozolomide—skin cancer	0.000455	0.00188	CcSEcCtD
Gadoxetate—Infection—Dactinomycin—skin cancer	0.000454	0.00188	CcSEcCtD
Gadoxetate—Palpitations—Temozolomide—skin cancer	0.000448	0.00185	CcSEcCtD
Gadoxetate—Cough—Temozolomide—skin cancer	0.000442	0.00183	CcSEcCtD
Gadoxetate—Paraesthesia—Bleomycin—skin cancer	0.00044	0.00182	CcSEcCtD
Gadoxetate—Vision blurred—Fluorouracil—skin cancer	0.00044	0.00182	CcSEcCtD
Gadoxetate—Convulsion—Temozolomide—skin cancer	0.000439	0.00182	CcSEcCtD
Gadoxetate—Vomiting—Imiquimod—skin cancer	0.000439	0.00181	CcSEcCtD
Gadoxetate—Dyspnoea—Bleomycin—skin cancer	0.000437	0.00181	CcSEcCtD
Gadoxetate—Anorexia—Dactinomycin—skin cancer	0.000436	0.0018	CcSEcCtD
Gadoxetate—Rash—Imiquimod—skin cancer	0.000435	0.0018	CcSEcCtD
Gadoxetate—Dermatitis—Imiquimod—skin cancer	0.000435	0.0018	CcSEcCtD
Gadoxetate—Headache—Imiquimod—skin cancer	0.000432	0.00179	CcSEcCtD
Gadoxetate—Anxiety—Temozolomide—skin cancer	0.00043	0.00178	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000428	0.00177	CcSEcCtD
Gadoxetate—Discomfort—Temozolomide—skin cancer	0.000426	0.00176	CcSEcCtD
Gadoxetate—Decreased appetite—Bleomycin—skin cancer	0.000426	0.00176	CcSEcCtD
Gadoxetate—Acute coronary syndrome—Docetaxel—skin cancer	0.000425	0.00176	CcSEcCtD
Gadoxetate—Renal failure—Docetaxel—skin cancer	0.000424	0.00175	CcSEcCtD
Gadoxetate—Myocardial infarction—Docetaxel—skin cancer	0.000423	0.00175	CcSEcCtD
Gadoxetate—Dry mouth—Temozolomide—skin cancer	0.000422	0.00174	CcSEcCtD
Gadoxetate—Conjunctivitis—Docetaxel—skin cancer	0.000419	0.00173	CcSEcCtD
Gadoxetate—Anaphylactic shock—Temozolomide—skin cancer	0.000414	0.00171	CcSEcCtD
Gadoxetate—Oedema—Temozolomide—skin cancer	0.000414	0.00171	CcSEcCtD
Gadoxetate—Infection—Temozolomide—skin cancer	0.000411	0.0017	CcSEcCtD
Gadoxetate—Nausea—Imiquimod—skin cancer	0.00041	0.00169	CcSEcCtD
Gadoxetate—Nervous system disorder—Temozolomide—skin cancer	0.000406	0.00168	CcSEcCtD
Gadoxetate—Convulsion—Fluorouracil—skin cancer	0.000405	0.00167	CcSEcCtD
Gadoxetate—Feeling abnormal—Bleomycin—skin cancer	0.000404	0.00167	CcSEcCtD
Gadoxetate—Skin disorder—Temozolomide—skin cancer	0.000402	0.00166	CcSEcCtD
Gadoxetate—Hyperhidrosis—Temozolomide—skin cancer	0.0004	0.00165	CcSEcCtD
Gadoxetate—Chest pain—Fluorouracil—skin cancer	0.000397	0.00164	CcSEcCtD
Gadoxetate—Decreased appetite—Dactinomycin—skin cancer	0.000397	0.00164	CcSEcCtD
Gadoxetate—Fatigue—Dactinomycin—skin cancer	0.000394	0.00163	CcSEcCtD
Gadoxetate—Anorexia—Temozolomide—skin cancer	0.000394	0.00163	CcSEcCtD
Gadoxetate—Discomfort—Fluorouracil—skin cancer	0.000393	0.00162	CcSEcCtD
Gadoxetate—Urticaria—Bleomycin—skin cancer	0.000389	0.00161	CcSEcCtD
Gadoxetate—Rhinitis—Docetaxel—skin cancer	0.000388	0.0016	CcSEcCtD
Gadoxetate—Body temperature increased—Bleomycin—skin cancer	0.000388	0.0016	CcSEcCtD
Gadoxetate—Hypoaesthesia—Docetaxel—skin cancer	0.000385	0.00159	CcSEcCtD
Gadoxetate—Anaphylactic shock—Fluorouracil—skin cancer	0.000381	0.00158	CcSEcCtD
Gadoxetate—Oedema—Fluorouracil—skin cancer	0.000381	0.00158	CcSEcCtD
Gadoxetate—Connective tissue disorder—Docetaxel—skin cancer	0.00038	0.00157	CcSEcCtD
Gadoxetate—Infection—Fluorouracil—skin cancer	0.000379	0.00157	CcSEcCtD
Gadoxetate—Feeling abnormal—Dactinomycin—skin cancer	0.000377	0.00156	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Dactinomycin—skin cancer	0.000374	0.00155	CcSEcCtD
Gadoxetate—Nervous system disorder—Fluorouracil—skin cancer	0.000374	0.00154	CcSEcCtD
Gadoxetate—Tachycardia—Fluorouracil—skin cancer	0.000372	0.00154	CcSEcCtD
Gadoxetate—Paraesthesia—Temozolomide—skin cancer	0.000371	0.00154	CcSEcCtD
Gadoxetate—Dyspnoea—Temozolomide—skin cancer	0.000369	0.00152	CcSEcCtD
Gadoxetate—Anorexia—Fluorouracil—skin cancer	0.000363	0.0015	CcSEcCtD
Gadoxetate—Body temperature increased—Dactinomycin—skin cancer	0.000361	0.00149	CcSEcCtD
Gadoxetate—Abdominal pain—Dactinomycin—skin cancer	0.000361	0.00149	CcSEcCtD
Gadoxetate—Hypersensitivity—Bleomycin—skin cancer	0.000361	0.00149	CcSEcCtD
Gadoxetate—Decreased appetite—Temozolomide—skin cancer	0.000359	0.00149	CcSEcCtD
Gadoxetate—Cardiac disorder—Docetaxel—skin cancer	0.000359	0.00149	CcSEcCtD
Gadoxetate—Flushing—Docetaxel—skin cancer	0.000359	0.00149	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Temozolomide—skin cancer	0.000357	0.00148	CcSEcCtD
Gadoxetate—Fatigue—Temozolomide—skin cancer	0.000357	0.00147	CcSEcCtD
Gadoxetate—Hypotension—Fluorouracil—skin cancer	0.000356	0.00147	CcSEcCtD
Gadoxetate—Constipation—Temozolomide—skin cancer	0.000354	0.00146	CcSEcCtD
Gadoxetate—Asthenia—Bleomycin—skin cancer	0.000352	0.00145	CcSEcCtD
Gadoxetate—Angiopathy—Docetaxel—skin cancer	0.000351	0.00145	CcSEcCtD
Gadoxetate—Immune system disorder—Docetaxel—skin cancer	0.00035	0.00145	CcSEcCtD
Gadoxetate—Mediastinal disorder—Docetaxel—skin cancer	0.000349	0.00144	CcSEcCtD
Gadoxetate—Chills—Docetaxel—skin cancer	0.000347	0.00144	CcSEcCtD
Gadoxetate—Pruritus—Bleomycin—skin cancer	0.000347	0.00143	CcSEcCtD
Gadoxetate—Arrhythmia—Docetaxel—skin cancer	0.000346	0.00143	CcSEcCtD
Gadoxetate—Paraesthesia—Fluorouracil—skin cancer	0.000342	0.00141	CcSEcCtD
Gadoxetate—Feeling abnormal—Temozolomide—skin cancer	0.000341	0.00141	CcSEcCtD
Gadoxetate—Dyspnoea—Fluorouracil—skin cancer	0.00034	0.0014	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Temozolomide—skin cancer	0.000338	0.0014	CcSEcCtD
Gadoxetate—Hypersensitivity—Dactinomycin—skin cancer	0.000337	0.00139	CcSEcCtD
Gadoxetate—Decreased appetite—Fluorouracil—skin cancer	0.000331	0.00137	CcSEcCtD
Gadoxetate—Dysgeusia—Docetaxel—skin cancer	0.00033	0.00136	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000329	0.00136	CcSEcCtD
Gadoxetate—Urticaria—Temozolomide—skin cancer	0.000329	0.00136	CcSEcCtD
Gadoxetate—Asthenia—Dactinomycin—skin cancer	0.000328	0.00136	CcSEcCtD
Gadoxetate—Abdominal pain—Temozolomide—skin cancer	0.000327	0.00135	CcSEcCtD
Gadoxetate—Body temperature increased—Temozolomide—skin cancer	0.000327	0.00135	CcSEcCtD
Gadoxetate—Back pain—Docetaxel—skin cancer	0.000326	0.00135	CcSEcCtD
Gadoxetate—Feeling abnormal—Fluorouracil—skin cancer	0.000314	0.0013	CcSEcCtD
Gadoxetate—Diarrhoea—Dactinomycin—skin cancer	0.000313	0.00129	CcSEcCtD
Gadoxetate—Vomiting—Bleomycin—skin cancer	0.000312	0.00129	CcSEcCtD
Gadoxetate—Rash—Bleomycin—skin cancer	0.000309	0.00128	CcSEcCtD
Gadoxetate—Dermatitis—Bleomycin—skin cancer	0.000309	0.00128	CcSEcCtD
Gadoxetate—Hypersensitivity—Temozolomide—skin cancer	0.000305	0.00126	CcSEcCtD
Gadoxetate—Urticaria—Fluorouracil—skin cancer	0.000303	0.00125	CcSEcCtD
Gadoxetate—Syncope—Docetaxel—skin cancer	0.000302	0.00125	CcSEcCtD
Gadoxetate—Body temperature increased—Fluorouracil—skin cancer	0.000301	0.00125	CcSEcCtD
Gadoxetate—Palpitations—Docetaxel—skin cancer	0.000298	0.00123	CcSEcCtD
Gadoxetate—Asthenia—Temozolomide—skin cancer	0.000297	0.00123	CcSEcCtD
Gadoxetate—Loss of consciousness—Docetaxel—skin cancer	0.000296	0.00122	CcSEcCtD
Gadoxetate—Cough—Docetaxel—skin cancer	0.000294	0.00122	CcSEcCtD
Gadoxetate—Pruritus—Temozolomide—skin cancer	0.000293	0.00121	CcSEcCtD
Gadoxetate—Convulsion—Docetaxel—skin cancer	0.000292	0.00121	CcSEcCtD
Gadoxetate—Nausea—Bleomycin—skin cancer	0.000291	0.0012	CcSEcCtD
Gadoxetate—Vomiting—Dactinomycin—skin cancer	0.000291	0.0012	CcSEcCtD
Gadoxetate—Rash—Dactinomycin—skin cancer	0.000288	0.00119	CcSEcCtD
Gadoxetate—Chest pain—Docetaxel—skin cancer	0.000287	0.00119	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000285	0.00118	CcSEcCtD
Gadoxetate—Diarrhoea—Temozolomide—skin cancer	0.000283	0.00117	CcSEcCtD
Gadoxetate—Hypersensitivity—Fluorouracil—skin cancer	0.000281	0.00116	CcSEcCtD
Gadoxetate—Dry mouth—Docetaxel—skin cancer	0.000281	0.00116	CcSEcCtD
Gadoxetate—Anaphylactic shock—Docetaxel—skin cancer	0.000275	0.00114	CcSEcCtD
Gadoxetate—Oedema—Docetaxel—skin cancer	0.000275	0.00114	CcSEcCtD
Gadoxetate—Dizziness—Temozolomide—skin cancer	0.000273	0.00113	CcSEcCtD
Gadoxetate—Infection—Docetaxel—skin cancer	0.000273	0.00113	CcSEcCtD
Gadoxetate—Nausea—Dactinomycin—skin cancer	0.000272	0.00112	CcSEcCtD
Gadoxetate—Shock—Docetaxel—skin cancer	0.000271	0.00112	CcSEcCtD
Gadoxetate—Nervous system disorder—Docetaxel—skin cancer	0.00027	0.00112	CcSEcCtD
Gadoxetate—Pruritus—Fluorouracil—skin cancer	0.00027	0.00111	CcSEcCtD
Gadoxetate—Tachycardia—Docetaxel—skin cancer	0.000268	0.00111	CcSEcCtD
Gadoxetate—Skin disorder—Docetaxel—skin cancer	0.000267	0.0011	CcSEcCtD
Gadoxetate—Vomiting—Temozolomide—skin cancer	0.000263	0.00109	CcSEcCtD
Gadoxetate—Anorexia—Docetaxel—skin cancer	0.000262	0.00108	CcSEcCtD
Gadoxetate—Rash—Temozolomide—skin cancer	0.000261	0.00108	CcSEcCtD
Gadoxetate—Diarrhoea—Fluorouracil—skin cancer	0.000261	0.00108	CcSEcCtD
Gadoxetate—Dermatitis—Temozolomide—skin cancer	0.000261	0.00108	CcSEcCtD
Gadoxetate—Headache—Temozolomide—skin cancer	0.000259	0.00107	CcSEcCtD
Gadoxetate—Hypotension—Docetaxel—skin cancer	0.000257	0.00106	CcSEcCtD
Gadoxetate—Dizziness—Fluorouracil—skin cancer	0.000252	0.00104	CcSEcCtD
Gadoxetate—Paraesthesia—Docetaxel—skin cancer	0.000247	0.00102	CcSEcCtD
Gadoxetate—Nausea—Temozolomide—skin cancer	0.000246	0.00102	CcSEcCtD
Gadoxetate—Dyspnoea—Docetaxel—skin cancer	0.000245	0.00101	CcSEcCtD
Gadoxetate—Vomiting—Fluorouracil—skin cancer	0.000242	0.001	CcSEcCtD
Gadoxetate—Rash—Fluorouracil—skin cancer	0.00024	0.000993	CcSEcCtD
Gadoxetate—Dermatitis—Fluorouracil—skin cancer	0.00024	0.000992	CcSEcCtD
Gadoxetate—Decreased appetite—Docetaxel—skin cancer	0.000239	0.000988	CcSEcCtD
Gadoxetate—Headache—Fluorouracil—skin cancer	0.000239	0.000987	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Docetaxel—skin cancer	0.000237	0.000982	CcSEcCtD
Gadoxetate—Fatigue—Docetaxel—skin cancer	0.000237	0.00098	CcSEcCtD
Gadoxetate—Constipation—Docetaxel—skin cancer	0.000235	0.000972	CcSEcCtD
Gadoxetate—Feeling abnormal—Docetaxel—skin cancer	0.000227	0.000937	CcSEcCtD
Gadoxetate—Nausea—Fluorouracil—skin cancer	0.000226	0.000936	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Docetaxel—skin cancer	0.000225	0.00093	CcSEcCtD
Gadoxetate—Abdominal pain—Docetaxel—skin cancer	0.000217	0.000899	CcSEcCtD
Gadoxetate—Body temperature increased—Docetaxel—skin cancer	0.000217	0.000899	CcSEcCtD
Gadoxetate—Hypersensitivity—Docetaxel—skin cancer	0.000203	0.000838	CcSEcCtD
Gadoxetate—Asthenia—Docetaxel—skin cancer	0.000197	0.000816	CcSEcCtD
Gadoxetate—Pruritus—Docetaxel—skin cancer	0.000195	0.000804	CcSEcCtD
Gadoxetate—Diarrhoea—Docetaxel—skin cancer	0.000188	0.000778	CcSEcCtD
Gadoxetate—Dizziness—Docetaxel—skin cancer	0.000182	0.000752	CcSEcCtD
Gadoxetate—Vomiting—Docetaxel—skin cancer	0.000175	0.000723	CcSEcCtD
Gadoxetate—Rash—Docetaxel—skin cancer	0.000173	0.000717	CcSEcCtD
Gadoxetate—Dermatitis—Docetaxel—skin cancer	0.000173	0.000716	CcSEcCtD
Gadoxetate—Headache—Docetaxel—skin cancer	0.000172	0.000712	CcSEcCtD
Gadoxetate—Nausea—Docetaxel—skin cancer	0.000163	0.000675	CcSEcCtD
